Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life

Sponsor
Mohamed Adel Abdellah (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05671575
Collaborator
(none)
150
1
12
12.5

Study Details

Study Description

Brief Summary

Epilepsy is a common neurological condition that affects personal and familial behavior and social support . About 50 million people worldwide suffer from epilepsy and the prevalence of active epilepsy in developing countries is 5 to 10 per 100 persons . Individuals with epilepsy may suffer from psychological issues such as depression, anxiety, and psychosis . Accordingly, living with a person with epilepsy will provide some challenges, particularly at home. Studies have reported that relatives of people with epilepsy have an increased risk of anxiety. Epilepsy can inflict an enormous burden on both the people with epilepsy (PWE) and their family caregivers, decreasing their quality of life and daily efficiency.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire about Epilepsy

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
A Study of The Knowledge and Attitude Towards Epilepsy Among Close Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Knowledge and attitudes toward epilepsy among close Relatives of people with Epilepsy. [1 year]

    This study will be conducted to assess the degree of knowledge and attitudes toward epilepsy among close Relatives of people with Epilepsy. A structured questionnaire will be administered to the accompanying relative. The questionnaire will assess this knowledge and the sources that close relatives obtain this knowledge from, including general attitude towards the People with epilepsy, and contains section that assess sigma about epilepsy using Stigma scale of epilepsy.

  2. Quality of life of people with epilepsy. [1 year]

    We will use the Quality of life in epilepsy-10 inventory (QOLIE-10) as the main collection tool as regard quality of life of people with epilepsy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 110 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • The participants Will be the close relatives of people with epilepsy who had a close relationship with the patient and living in the same house. The respondents will include the mothers, fathers, brothers, sisters, or the husband/wife, sons of patients.

The patients will be patients diagnosed of epilepsy for at least 6 months, who were using antiepileptic drugs.

Exclusion Criteria:
  • The Relatives not living in the same house or not in direct contact with the patients or younger than 16 years old will be excluded from the study.

The persons who had major medical or mental health problems other than epilepsy that would affect QOL will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag university hospital Sohag Egypt 82611

Sponsors and Collaborators

  • Mohamed Adel Abdellah

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Mohamed Adel Abdellah, neuropsychiatry resident, Sohag University
ClinicalTrials.gov Identifier:
NCT05671575
Other Study ID Numbers:
  • Soh-Med-22-11-05
First Posted:
Jan 4, 2023
Last Update Posted:
Jan 4, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mohamed Adel Abdellah, neuropsychiatry resident, Sohag University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 4, 2023